BioSpace News Archive

Business

Mother Delivers Healthy Full Term Twins After Water Breaks at 14 Weeks With Support From The PPROM Foundation

The PPROM Foundation calls for research and awareness of PPROM in early pregnancy

July 22, 2019
·
2 min read
Business

Texas Based CMO VGXI and Geneos Therapeutics Establish Supply Agreement for Production of GT-EPIC-Based Personalized Cancer Therapeutics

Plasmid CMO VGXI, Inc. and Geneos Therapeutics, Inc., a spin-out of Inovio Pharmaceuticals (NASDAQ: INO) focused on developing DNA-based, Neoantigen-targeting personalized cancer immunotherapies, announced today they have entered into a long-term master supply agreement.

July 22, 2019
·
6 min read
Huge CPhI & P-MEC China a direct result of surging manufacturing

CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow.

July 22, 2019
·
5 min read
Policy

Government of Canada hosts joint exercises in Quebec and Western Provinces to support African swine fever (ASF) mitigation and preparedness

Statement from Canada’s Chief Veterinary Officer

July 22, 2019
·
2 min read
Business

BioSpace Life Sciences Compensation Report Finds Growing Salaries but a Wide Gender Gap

According to a new report by BioSpace, the life science leader in news and careers, more than 65% of life science professionals received a salary increase in the last year with the average increase being 4.4%.

July 22, 2019
·
2 min read
Business

Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2019 on Wednesday, July 31, 2019, after the market closes.

July 22, 2019
·
1 min read
Drug Development

ACADIA Pharmaceuticals Announces Top-line Results from Phase 3 ENHANCE Trial of Pimavanserin as Adjunctive Treatment for Patients with Schizophrenia

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), today announced top-line results from its Phase 3 ENHANCE study, which evaluated pimavanserin as an adjunctive treatment in adult schizophrenia patients with persistent inadequate response to their current antipsychotic therapy.

July 22, 2019
·
10 min read
Deals

Haemonetics Corporation Updates Financial Reporting Segments

Haemonetics Corporation announced changes to its financial reporting segments and business units.

July 22, 2019
·
3 min read
Deals

BD Board Declares Dividends, payable on September 30, 2019

The Board of Directors of BD has declared a quarterly dividend of $0.77 per common share, payable on September 30, 2019 to holders of record on September 9, 2019.

July 22, 2019
·
1 min read
BioCapital

FDA In Brief: FDA reinforces need for applicants to submit thorough and timely safety information for combination medical products

“In the past decade we have seen a marked increase in interest from manufacturers who seek to develop medical products that combine devices, drugs and/or biologics.

July 22, 2019
·
3 min read